|Articles|October 1, 2016
- BioPharm International-10-01-2016
- Volume 29
- Issue 10
BioPharm International, October 2016 Issue (PDF)
Click the title above to open the BioPharm International October 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Defining Risk Assessment of Aseptic Processesover 9 years ago
Real Time Continuous Microbiological Monitoringover 9 years ago
Optimizing Temperature Control for Biopharmaceuticalsover 9 years ago
HPLE Sugars Improve Stability and Drug Productover 9 years ago
Calling All Authorsover 9 years ago
Multiparticulate technologies hot for controlled releaseover 9 years ago
New Drug-Delivery Methods: From Concept to Patientover 9 years ago
Manufacturers Face Major Changes under PDUFA VIover 9 years ago
Fill/Finish OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
